retatrutide trial news from TRIUMPH-1, a Phase 3 of retatrutide, the first-in-class GIP/GLP-1/GCGR agonist investigating the effect of adding glucagon receptor activation on top of the dual mechanism of… Eli Lilly retatrutide Phase 3

Upon entering systemic circulation, liraglutide demonstrates a notable affinity to bind to serum albumin (around 99%), leading to increased resistance to enzymatic breakdown by DPP-IV and NEP and a subsequent decrease in kidney-based elimination

Each new study adds to the picture that injectable GLP-1 receptor agonists do not transfer into breast milk in meaningful amounts

Related resources In case I dont see you, good afternoon, good evening, and good night

Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na + K + -ATPase activity and motor conduction velocity in the streptozotocin diabetic rat